UU Framework uses new HACH LANGE sensors
May 27, 2009
United Utilities has extended its Framework Agreement with HACH LANGEand added two new sensors; the LDO™ (Luminescent Dissolved Oxygen) sensor and the NH4D ammonium sensor. United Utilities and HACH LANGE have extended a Framework Agreement originally signed in May 2006 and added two new sensors; the LDO™ (Luminescent Dissolved Oxygen) sensor and the NH4D ammonium [...]
HORIBA Introduces New Division and Team
May 27, 2009
Chemistry and haematology bench top analysis anywhere PRLog (Press Release) – May 27, 2009 – Northampton, UK: Renowned specialists in the design and manufacture of systems and instruments for analysing and measuring gases, liquids and solids, the HORIBA Group introduces its newest division - HORIBA Medical which specialises in automated in vitro diagnostics. Although the [...]
Gene Network Sciences Announces Broad Cancer Collaboration With UCSF and Initial Results
May 27, 2009
CAMBRIDGE, Mass., May 27 -- Gene Network Sciences, Inc. (GNS) today announced that it has entered into a research collaboration with the University of California San Francisco Cancer Center (UCSF) aimed at accelerating cancer research and drug development across several therapeutic areas. This collaboration will combine the clinical and research oncology expertise of UCSF with [...]
ForteBio Launches New Assay Capabilities
May 27, 2009
ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on its Octet® Platform MENLO PARK, Calif. — ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced that it has launched two new assay modules – for high-sensitivity protein quantitation and fragment screening, [...]
Proteome Sciences plc (‘Proteome Sciences’) License Agreement in Brain Damage
May 27, 2009
27th May, 2009 Proteome Sciences plc has entered into a license agreement with Axela Inc. for the development of assays to measure its proprietary brain damage biomarkers on Axela's multiplex biomarker assay dotLab™ System. Proteome Sciences has established a strong portfolio of patent protected blood biomarkers of brain damage-related disorders working in collaboration with the [...]
Dual block cycling for under Euros 5k
May 27, 2009
G-Storm GS482 meets growing need for “personal” instruments Braintree, UK, May 27, 2009: Gene Technologies Ltd, the UK-based life sciences instrumentation manufacturer today announced the launch of the GS-482, the latest thermal cycler in the highly successful G-Storm range. In the current difficult climate, the GS 482 thermal cycler is an ideal solution for scientists [...]
May 27, 2009
VENLO, Netherlands--QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it has entered into an agreement to supply molecular sample and assay technologies for a new national, PCR-based blood screening program for HIV and Hepatitis C (HCV) in Brazil. QIAGEN will provide Bio-Manguinhos, the main provider of vaccines and diagnostics to the Brazilian Ministry [...]
May 27, 2009
MENLO PARK, Calif., May 27 -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced that it has launched two new assay modules - for high-sensitivity protein quantitation and fragment screening, respectively - for use on the company's Octet(R) instrumentation platform. The new modules are [...]
GenoLogics, JMP Genomics To Provide End-to-End Data Management And Analysis
May 27, 2009
VICTORIA, British Columbia Canada/EWORLDWIRE/May 27, 2009 --- GenoLogics and SAS today announced plans to integrate the Geneus lab and data management solution with the JMP(R) Genomics statistical discovery application from SAS to provide a comprehensive system for managing and analyzing large genomic data sets. Together, Geneus and JMP Genomics will offer genomics centers a powerful [...]
Evotec Streamlines Testing of Quarter Million Compounds with Promega HaloTag® Technology
May 27, 2009
MADISON, Wis.--Evotec recently completed its largest screening project with the use of Promega HaloTag® technology. Evotec reported screening over 250,000 unique compounds on live cells with an assay designed to detect the internalization of a novel membrane receptor. The results identified compounds that have potential to be first in class for the therapeutic area. After [...]
